8-K: Odyssey Health Extends Maturity Dates on Promissory Notes to July 31, 2025
Current Report (Form 8-K)
Odyssey Health, Inc. has extended the maturity dates of two promissory notes with Jon Lutz and LGH Investments, LLC to July 31, 2025.
Summary
- Odyssey Health, Inc. filed a Form 8-K on February 19, 2025, reporting the extension of maturity dates for two promissory notes.
- Amendment No. 3 to the Promissory Note with Jon Lutz, dated February 13, 2024, extends the maturity date to July 31, 2025.
- Amendment No. 9 to the Convertible Promissory Note with LGH Investments, LLC, dated April 5, 2021, extends the maturity date to July 31, 2025, effective December 31, 2024.
- All other terms and conditions of the notes remain the same.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the announcement simply reflects an extension of debt maturity dates, which is a common financial maneuver. It doesn't inherently indicate positive or negative performance.
Risks
- The company's reliance on debt financing could pose a risk if it is unable to meet its obligations or refinance the debt in the future.
Future Outlook
The document does not contain specific forward-looking statements beyond the extended maturity dates of the notes.
Management Comments
- J. Michael Redmond, Chief Executive Officer of Odyssey Health, signed both amendments on behalf of the company.
Industry Context
Extending maturity dates on promissory notes is a common practice for companies seeking to manage their short-term debt obligations, especially in the biotechnology and pharmaceutical industries where long development cycles are common.
Comparison to Industry Standards
- It's difficult to compare this specific transaction to industry standards without knowing the interest rates and other terms of the notes.
- However, extending maturity dates is a fairly common practice, especially for smaller companies in the biotech sector.
- Similar companies might include those listed on the OTC market that are in early stages of development and rely on convertible debt financing.
Stakeholder Impact
- Shareholders may be impacted by the company's continued reliance on debt financing.
- Creditors, specifically Jon Lutz and LGH Investments, LLC, are impacted by the extension of the maturity dates of the notes.
Key Dates
| Date | Description |
|---|---|
| April 5, 2021 | Date of the Securities Purchase Agreement with LGH Investments, LLC |
| February 13, 2024 | Date of the Promissory Note with Jon Lutz |
| December 31, 2024 | Effective date of Amendment No. 9 to the Convertible Promissory Note with LGH Investments, LLC |
| February 13, 2025 | Date of Amendment No. 3 to the Promissory Note with Jon Lutz |
| February 19, 2025 | Date of the 8-K filing |
| July 31, 2025 | New maturity date for both the Promissory Note with Jon Lutz and the Convertible Promissory Note with LGH Investments, LLC |
Keywords
promissory note, maturity date, extension, convertible note, debt, financing, Odyssey Health, LGH Investments, Jon Lutz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.